Biotech News

Nanobiotix to Participate in Investor Conferences in November

Nanobiotix (NBTX)NanobiotixCompany update

NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in the following investor conferences in November:

Related news

Nanobiotix

Physics-Based Nanotherapeutics Company Nanobiotix develops nanoparticle-based therapies intended to enhance the effects of established cancer treatments. Its lead program uses a physical interaction with radiotherapy rather than a tumor-specific biological target. JNJ-1900 Radioenhancer JNJ-1900, formerly NBTXR3, consists of...

Recent company news

Stock data

Close
27.32 USD
Market cap
1.86B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States